Cardiomyopathy, Hypertrophic Clinical Trials
2 recruiting trials for Cardiomyopathy, Hypertrophic. Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT07077005
Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy
Patients with hypertrophic obstructive cardiomyopathy and New York Heart Association Class I-II under stable treatment with mavacamten (at least 12 weeks without change of dosage)...
Sponsor: Technical University of MunichEnrolling: 241 location
RECRUITINGNCT06546137
National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's...
The goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data. The main...
Sponsor: Hospital do CoracaoEnrolling: 60020 locations